Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Oral Tolerance MiraLAX Solution Concentrate in Subjects With Chronic Constipation

NCT01885104 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01885104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01885104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Oral Tolerance MiraLAX Solution Concentrate in Subjects With Chronic Constipation
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2013
Completion date
October 31, 2013
Enrollment
65 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

constipation